AlphaQuest LLC reduced its position in Intellia Therapeutics, Inc. (NASDAQ:NTLA – Free Report) by 57.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 22,215 shares of the company’s stock after selling 29,619 shares during the quarter. AlphaQuest LLC’s holdings in Intellia Therapeutics were worth $208,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Get Intellia Therapeut ...